Rapid Dose Therapeutics Corp.
Rapid Dose Therapeutics Corp. is a publicly traded Canadian life sciences company that provides innovative, proprietary drug delivery technologies designed to improve outcomes and quality of lives. RDT offers Quick, Convenient, Precise and Discreet™ choices to consumers. RDT is focused and committed to clinical research and product development for the healthcare manufacturing industry, including nutraceutical, pharmaceutical and cannabis industries.
Within the cannabis sector, RDT provides a turn-key business solution which enables RDT’s QuickStrip™ proprietary drug delivery technology to be licensed by select partners. RDT’s service-based annuity contracts drive recurring revenue which enables rapid expansion into emerging markets — generating value for consumers and shareholders. RDT is committed to continually create innovative solutions aimed at multiple consumer segments and future market needs — including humans, animals and plants.
Rapid Dose Therapeutics Corp. (DOSE)
Communiqués de presse
Le 19 novembre/November 2020
Effective immediately, Rapid Dose Therapeutics Corp. will be reinstated for trading.
The Company has rectified the default situation that gave rise to the suspension.
À compter de maintenant, Rapid Dose Therapeutics Corp. sera rétablie à des fins de négociation.
La Société a rectifié la situation de défaut ayant donné lieu à la suspension.